Literature DB >> 6404388

Hyperkalaemia in patients in hospital.

B Paice, J M Gray, D McBride, T Donnelly, D H Lawson.   

Abstract

Significant hyperkalaemia occurred in 406 out of 29 063 patients admitted to a major Scottish teaching hospital in one year (1.4%). Mortality was higher in these patients than in control patients and was strongly correlated with the severity of the hyperkalaemia. Overall seven deaths were directly due to hyperkalaemia (out of 58 deaths among patients with hyperkalaemia). Factors contributing to a poor prognosis were severity and speed of onset of hyperkalaemia and the presence of appreciable renal impairment. Patients with hyperkalaemia were older and more likely to be male; this trend was present in all diagnostic subcategories. Genitourinary disease, gastrointestinal disease, and cancer were significantly more common among the patients with hyperkalaemia than the controls. Hyperkalaemia due to drug treatment was invariably mild and non-fatal, whereas genitourinary disease was often associated with moderate to severe hyperkalaemia, which in two cases proved fatal. Use of electrocardiographic monitoring was rare, and although the treatment of hyperkalaemia was effective, it was often used when not required. Hyperkalaemia is a potential hazard in diabetic ketoacidosis, and use of potassium supplements should be carefully monitored during correction of the acidosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404388      PMCID: PMC1547392          DOI: 10.1136/bmj.286.6372.1189

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

1.  Hyperkalemia and hypokalemia.

Authors:  S R Newmark; R G Dluhy
Journal:  JAMA       Date:  1975-02-10       Impact factor: 56.272

2.  Adverse reactions to potassium chloride.

Authors:  D H Lawson
Journal:  Q J Med       Date:  1974-07

3.  Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  JAMA       Date:  1973-07-02       Impact factor: 56.272

4.  Fatal drug reactions among medical inpatients.

Authors:  S Shapiro; D Slone; G P Lewis; H Jick
Journal:  JAMA       Date:  1971-04-19       Impact factor: 56.272

5.  Pseudohyperkalemia due to release of potassium from white blood cells during clotting.

Authors:  W R Bronson; V T DeVita; P P Carbone; E Cotlove
Journal:  N Engl J Med       Date:  1966-02-17       Impact factor: 91.245

6.  Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K.

Authors:  B Surawicz; H Chlebus; A Mazzoleni
Journal:  Am Heart J       Date:  1967-05       Impact factor: 4.749

7.  Severe hypokalemia in hospitalized patients.

Authors:  D H Lawson; D A Henry; J M Lowe; J M Gray; H G Morgan
Journal:  Arch Intern Med       Date:  1979-09

8.  Management of emergencies. VI. Hyperkalemia.

Authors:  N G Levinsky
Journal:  N Engl J Med       Date:  1966-05-12       Impact factor: 91.245

9.  Low-dose insulin in the treatment of diabetic ketoacidosis.

Authors:  K G Alberti
Journal:  Arch Intern Med       Date:  1977-10

10.  Drug attributed alterations in potassium handling in congestive cardiac failure.

Authors:  D H Lawson; P C O'Connor; H Jick
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  10 in total
  26 in total

Review 1.  Management of patients with acute hyperkalemia.

Authors:  Meghan J Elliott; Paul E Ronksley; Catherine M Clase; Sofia B Ahmed; Brenda R Hemmelgarn
Journal:  CMAJ       Date:  2010-09-20       Impact factor: 8.262

2.  The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.

Authors:  Fawaz F Alharbi; Patrick C Souverein; Mark C H de Groot; Marieke T Blom; Anthonius de Boer; Olaf H Klungel; Hanno L Tan
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

3.  Association between hyperkalemia at critical care initiation and mortality.

Authors:  Gearoid M McMahon; Mallika L Mendu; Fiona K Gibbons; Kenneth B Christopher
Journal:  Intensive Care Med       Date:  2012-07-18       Impact factor: 17.440

Review 4.  Emergency interventions for hyperkalaemia.

Authors:  B A Mahoney; W A D Smith; D S Lo; K Tsoi; M Tonelli; C M Clase
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

5.  Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia.

Authors:  Josh Batterink; Jane Lin; Sarah Hin Mui Au-Yeung; Tara Cessford
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

6.  Retrospective review of the frequency of ECG changes in hyperkalemia.

Authors:  Brian T Montague; Jason R Ouellette; Gregory K Buller
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

Review 7.  Clinical features and management of poisoning due to potassium chloride.

Authors:  K Saxena
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

8.  Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases.

Authors:  Omalhassan Amir; Yahaya Hassan; Azmi Sarriff; Ahmed Awaisu; Noorizan Abd Aziz; Omar Ismail
Journal:  Pharm World Sci       Date:  2009-03-03

9.  Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.

Authors:  Marianne A Kuijvenhoven; Eric A F Haak; Kim B Gombert-Handoko; Mirjam Crul
Journal:  Int J Clin Pharm       Date:  2013-08-22

Review 10.  Epidemiology, prognosis and management of potassium disorders in Covid-19.

Authors:  Maryam Noori; Seyed A Nejadghaderi; Mark J M Sullman; Kristin Carson-Chahhoud; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Rev Med Virol       Date:  2021-06-02       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.